Cell Counting Kit-8 (CCK-8) |
Catalog No.GK10001 |
Cell Counting Kit-8 (CCK-8) is a ready-to-use one-bottle solution which offers a simple, rapid, reliable and sensitive measurement of cell viability and cytotoxicity of various chemicals.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
- Adv Mater (2024):2401538.PMID:38738793
- Cell Host Microbe 32.12 (2024):2195-2211.PMID:39610253
- Brain Behav Immun 110 (2023):60-79.PMID:36754245
- Adv Sci 7.9 (2020):1902938.PMID:32382476
- Nat Commun 15.1 (2024):72.PMID:38167723
- ACS nano 17.7 (2023):7017-7034.PMID:36971310
- Nat Commun 15.1 (2024):3771.PMID:38704377
- Nat Commun 14.1 (2023):3877.PMID:37391428
- Autophagy 18.5 (2022):1049-1061.PMID:34517786
- Cancer Commun (2024).PMID:38512764
- Acs Nano (2024).PMID:39361472
- Adv Sci (2023):2301107.PMID:37097746
- Adv Sci 10.31 (2023):2301120.PMID:37688357
- Brain Behav Immun (2024).PMID:38565398
- Autophagy just-accepted (2024).PMID:39007910
- Adv-Sci 10.27 (2023):2302640.PMID:37485650
- Cancer Commun 43.5 (2023):582-612.PMID:37005481
- Adv Sci (2024):2401845.PMID:38757623
- Microbiome 12.1 (2024):152.PMID:39152482
- Adv Sci (2024):2402450.PMID:38952061
- Sci Adv 10.10 (2024):eadg7380.PMID:38457499
- Adv Sci (2024):2404365.PMID:39159143
- J Exp Clin Canc Res 41.1 (2022):293.PMID:36199122
- Emerg Microbes Infec 12.1 (2023):2204164.PMID:37060263
- Water Res (2024):121379.PMID:38422694
- Small (2024):2407674.PMID:39363789
- J Med Virol 95.10 (2023):e29171.PMID:37830751
- J Adv Res (2023).PMID:36933884
- Gut Microbes 17.1 (2025):2446376.PMID:39718561
- J Hazard Mater (2024):135904.PMID:39303616
- Theranostics 14.16 (2024):6161.PMID:39431016
- Mater Horiz (2024).PMID:39189308
- Cell Death Differ 30.10 (2023):2293-2308.PMID:37608075
- Small Methods (2024):2400223.PMID:38602202
- Theranostics 12.7 (2022):3488.PMID:35547749
- Gut Microbes 16.1 (2024):2347757.PMID:38773738
- Mater Horiz (2024).PMID:39189308
- EBioMedicine 99 (2024).PMID:38101299
- Cell Discov 6.1 (2020):96.PMID:33349633
- Acta Biomater 157 (2023):321-336.PMID:36481504
- J Immunother Cancer 12.3 (2024):e008054.PMID:38429070
- Sci Total Environ 878 (2023):162942.PMID:36940749
- Cell Discov 6.1 (2020):96.PMID:33349633
- Environ Sci Technol (2024).PMID:39364562
- Redox Biol 62 (2023):102663.PMID:36924682
- J Control Release 373 (2024):749-765.PMID:39084465
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Control Release 349 (2022):254-268.PMID:35803328
- J Control Release 365 (2024):301-316.PMID:38007195
- Redox Biol (2023):102983.PMID:38064762
- Environ Sci Technol 56.21 (2022):15096-15107.PMID:36099323
- J Control Release 360 (2023):647-659.PMID:37406817
- Water Res (2024):122403.PMID:39278116
- J Exp Clin Canc Res 41.1 (2022):1-15.PMID:34980201
- J Exp Clin Canc Res 43.1 (2024):187.PMID:38965580
- J Control Release 359 (2023):12-25.PMID:37244298
- Clin Transl Med 14.1 (2024):e1539.PMID:38224186
- J Exp Clin Canc Res 43.1 (2024):91.PMID:38528516
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Exp Clin Canc Res 39 (2020):1-13.PMID:32028978
- Adv Healthc Mater 13.8 (2024):2303215.PMID:38112062
- J Nanobiotechnol 22.1 (2024):1-21.PMID:38448959
- Acta Biomater (2024).PMID:38452962
- Pharmacol Res 187 (2023):106563.PMID:36410674
- J Nanobiotechnol 22.1 (2024):1-15.PMID:38790037
- Adv Healthc Mater (2024):2401061.PMID:38849128
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Cancer Lett (2024):216765.PMID:38408604
- J Neuroinflamm 20.1 (2023):1-16.PMID:36944954
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Environ Health Persp 131.6 (2023):067004.PMID:37267060
- Adv Healthc Mater 12.9 (2023):2202785.PMID:36541060
- Adv Healthc Mater (2024):2402877.PMID:39434433
- J Immunother Cancer 12.10 (2024):e009416.PMID:39455095
- Adv Healthc Mater 11.8 (2022):2102395.PMID:34874119
- Sci Total Environ 897 (2023):165514.PMID:37451464
- J Nanobiotechnol 21.1 (2023):354.PMID:37775761
- Pharmacol Res 195 (2023):106877.PMID:37524154
- Environ Pollut 334 (2023):122148.PMID:37419204
- Brit J Cancer (2024):1-9.PMID:38594370
- Cell Death Dis 13.10 (2022):858.PMID:36209201
- Pharmacol Res 180 (2022):106225.PMID:35452801
- Mol Ther-Nucl Acids 31 (2023):703-716.PMID:36923951
- Acs Appl Mater Inter 15.32 (2023):38294-38308.PMID:37542453
- Cell Death Dis 13.5 (2022):497.PMID:35614040
- Food Chem (2024):139505.PMID:38703732
- Cell Mol Life Sci 79.7 (2022):382.PMID:35751755
- Pharmacol Res (2024):107460.PMID:39393436
- Cancer Lett (2024):217418.PMID:39725146
- ACS Appl Mater Inter 14.13 (2022).PMID:35344348
- Cell Mol Biol Lett 29.1 (2024):103.PMID:38997648
- Acs Appl Mater Inter (2024).PMID:38345297
- Environ Pollut 338 (2023):122581.PMID:37748638
- Front Immunol 14 (2023):1130308.PMID:37006248
- Acs Appl Mater Inter 15.11 (2023).PMID:36897565
- Biomark Res 11.1 (2023):3PMID:36611218
- Acta Biomater 113 (2020):393-406.PMID:32629189
- Cell Mol Life Sci 80.3 (2023):61.PMID:36763212
- Liver Int 43.4 (2023):840-854.PMID:36737842
- Cell Commun Signal 22.1 (2024):1-19.PMID:38454413
- Int J Biol Macromol (2024):133667.PMID:38969038
- Phytomedicine 122 (2024):155091.PMID:37844378
- Cell Mol Life Sci 81.1 (2024):143.PMID:38493426
- Acs Sensors (2024).PMID:38958530
- Cell Death Dis 13.3 (2022):233.PMID:35288538
- Phytomedicine 122 (2024):155091.PMID:37844378
- Int J Biol Macromol 224 (2023):797-809.PMID:36283555
- Cell Mol Biol Lett 29.1 (2024):83.PMID:38822277
- Free Radical Bio Med 190 (2022):202-215.PMID:35985562
- Cell Commun Signal 22.1 (2024):293.PMID:38802896
- Mater Today Bio (2024):101019.PMID:38516170
- Biomater Sci-UK 10.17 (2022):5006-5017.PMID:35815806
- Oncogene (2023):1-13.PMID:37138031
- Int J Biol Macromol 222 (2022):1789-1800.PMID:36191790
- Int J of Bio Macromol (2024):132103.PMID:38719011
- Cell Mol Life Sci 81.1 (2024):32.PMID:38214780
- Environ Res (2024):118221.PMID:38246300
- Phytomedicine (2023):155270.PMID:38096717
- Int J Biol Macromol (2024):131928.PMID:38688339
- Antivir Res 205 (2022):105381.PMID:35835291
- Int J Biol Macromol(2023):125130.PMID:37263336
- Int J Biol Macromol (2024):129172.PMID:38176496
- Int J Biol Macromol 220 (2022):371-384.PMID:35970372
- Free Radical Bio Med 188 (2022):404-418.PMID:35787451
- Phytomedicine 118 (2023):154944.PMID:37393830
- Cell Death Dis 12.4 (2021):408.PMID:33859186
- Cell Commun Signal 22.1 (2024):1-23.PMID:39696352
- Acs Appl Mater Inter (2024).PMID:39448903
- Acs Appl Mater Inter (2024).PMID:39320506
- Int J Biol Macromol (2024):135562.PMID:39276884
- Int J Biol Macromol (2024):136818.PMID:39447809
- Int J Biol Macromol (2024):135979.PMID:39332550
- Cell Death Dis 15.11 (2024):826.PMID:39543094
- Int J Biol Macromol (2024):137561.PMID:39537068
- Cell Death Dis 12.8 (2021):779.PMID:34365463
- Life Sci 312 (2023):121092.PMID:36279968
- J Med Chem 65.4 (2021):2794-2808.PMID:33872498
- Food Chem Toxicol 148 (2021):111972.PMID:33421461
- J Cell Physiol 238.1 (2023):195-209.PMID:36436184
- Bba-Mol Basis Dis 1869.1 (2023):166571.PMID:36244542
- J Med Chem (2024).PMID:39292661
- Stem Cell Res Ther 15.1 (2024):1-18.PMID:39267160
- J Med Virol 96.11 (2024):e70049.PMID:39558699
- Wirel Commun Mob Com 2 (2022):3.PMID:36120596
- Cell Death Discov 10.1 (2024):97.PMID:38402198
- Life Sci 308 (2022):120925.PMID:36057399
- Biomed Pharmacother 174 (2024):116470.PMID:38565061
- Phytother Res (2024).PMID:38558449
- Front Cell Dev Biol 10 (2022):850708.PMID:35592246
- Biomed Pharmacother 179 (2024):117415.PMID:39265236
- Phytother Res 37.10 (2023):4639-4654.PMID:37394882
- Nanoscale 16.17 (2024):8479-8494.PMID:38590261
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Oncogenesis 11.1 (2022):21.PMID:35487890
- Ecotox Environ Safe 266 (2023):115571.PMID:37837696
- Plos Pathog 19.10 (2023):e1011702.PMID:37801439
- Anal Chem 95.31 (2023):11664-11671.PMID:37495553
- Ecotox Environ Safe 270 (2024):115813.PMID:38113798
- Cell Death Discov 9.1 (2023):415.PMID:37968255
- Stem Cell Res Ther 10.1 (2019):1-14.PMID:31847890
- J Mater Chem B 11.16 (2023):3740-3751.PMID:37067505
- Front Immunol 14 (2023):1111494.PMID:36817451
- Front Immunol 13 (2022):986214.PMID:36341437
- Front Immunol 13 (2022):902515.PMID:35874682
- Ecotox Environ Safe 262 (2023):115161.PMID:37356398
- Fertil Steril (2023).PMID:37178109
- Eur J Med Chem 238 (2022):114458.PMID:35635946
- Bioeng Transl Med 8.3 (2023):e10475.PMID:37206234
- Stem Cell Res Ther 15.1 (2024) 385.PMID:39468662
- Antioxid Redox Sign 37.13 (2022):867-886.PMID:35350885
- Plos Pathog 17.3 (2021):e1009393.PMID:33684175
- Virol Sin (2023).PMID:37331658
- Biomed Pharmacother 129 (2020):110315.PMID:32554246
- Cell Death Discov 10.1 (2024):7.PMID:38182573
- Biomed Pharmacother 130 (2020):110566.PMID:32755793
- J Gastroenterol (2023):1-14.PMID:37150773
- Bba Mol Basis Dis 1869.7 (2023):166725.PMID:37127173
- Biomed Pharmacother 168 (2023):115751.PMID:37879214
- Biomed Pharmacother 162 (2023):114602.PMID:37018993
- Biomed Pharmacother 122 (2020):109690.PMID:31786468
- Free Radical Bio Med (2024).PMID:38367927
- J Med Chem (2024).PMID:38315032
- Brit J Pharmacol (2024).PMID:38715438
- Biomed Pharmacother 158 (2023):114118.PMID:36527845
- Int J Nanomed (2024):13183-13199.PMID:39664759
- Phytomedicine 130 (2024):155744.PMID:38763011
- Biomed Pharmacother 177 (2024):117037.PMID:38959602
- Ecotox Environ Safe 280 (2024):116579.PMID:38865940
- Front Nutr 9 (2022):812623.PMID:35419394
- Biomed Pharmacother 165 (2023):115261.PMID:37549461
- Front Cell Dev Biol 9 (2021):696558.PMID:34447749
- Phytomedicine (2024):155859.PMID:38972239
- Front Immunol 14 (2023).PMID:37662906
- Cell Biol Toxicol 38.6 (2022):1121-1136.PMID:35348966
- Clin Epigenetics 14.1 (2022):1-12.PMID:35414117
- Mater Today Bio 15 (2022):100264.PMID:35517578
- Front Cell Dev Biol 9 (2021):749210.PMID:34676217
- Molecular Therapy Oncology 32.2 (2024).PMID:38948919
- Cancer Cell Int 20 (2020):1-14.PMID:33292221
- Phytother Res (2023).PMID:37246830
- Biochem Pharmacol 213 (2023):115592.PMID:37196680
- Mol Med 30.1 (2024):14.PMID:38254010
- Aging (Albany NY) 13.3 (2021):4482.PMID:33495411
- Cancer Gene Ther 29.8-9 (2022):1228-1239.PMID:35115683
- Biochem Pharmacol (2024):116044.PMID:38336157
- Front Immunol 15 (2024):1455996.PMID:39376562
- Front Immunol 15 (2024):1375781.PMID:39391314
- Faseb J 37.5 (2023):e22935.PMID:37086094
- Phytother Res (2023).PMID:37086359
- Front Oncol 13 (2023):1120103.PMID:36959804
- Chinese Med J-Peking 136.05 (2023):556-564.PMID:36939243
- Life Sci (2024):122483.PMID:38307238
- Mbio (2023):e01688-23.PMID:37882780
- Aging (Albany NY) 15.12 (2023):5673.PMID:37387540
- J Transl Med 22.1 (2024):1-19.PMID:39107788
- Colloid Surface B 222 (2023):113119.PMID:36621177
- Cell Mol Life Sci 81.1 (2024):265.PMID:38880863
- Microbiol Res (2024):127927.PMID:39393129
- Mol Med 30 (2024):260.PMID:39707194
- Front Pharmacol 12 (2021):610158.PMID:33762939
- Chinese Med J-Peking (2023):10-1097.PMID:36939243
- Mol Neurobiol 58 (2021):1990-2004.PMID:33411316
- J Agr Food Chem 71.3 (2023):1593-1606.PMID:36634077
- Eur J Pharm Biopharm 188 (2023):89-99.PMID:36702198
- Biomater Adv (2024):214069.PMID:39447240
- Jci Insight (2024). PMID:38935435
- J Agr Food Chem (2023).PMID:37922022
- Front Oncol 12 (2022):858598.PMID:35321435
- Cells 11.24 (2022):4094.PMID:36552856
- Lab Invest 102.4 (2022):411-421.PMID:34775495
- Front Pharmacol 13 (2022):819826.PMID:35645824
- Front Pharmacol 13 (2022):965131.PMID:36249790
- Front Pharmacol 13 (2022):972397.PMID:36188529
- Int J Mol Sci 24.22 (2023):16503.PMID:38003694
- Front Pharmacol 13 (2022):1015693.PMID:36210855
- Cells 11.23 (2022):3816.PMID:36497076
- Front Pharmacol 14 (2023):1168393.PMID:37124212
- Int J Pharmaceut (2023):123142.PMID:37328119
- Int J Mol Sci 23.24(2022):16045.PMID:36555684
- Ecotox Environ Safe 287 (2024):117331.PMID:39547060
- Aging (Albany NY) 13.17 (2021):21712.PMID:34518442
- Int J Mol Sci 22.21 (2021):11893.PMID:34769322
- Front Cell Dev Biol 10 (2022):787730.PMID:35445026
- Front Pharmacol 11 (2020):16.PMID:32140106
- Front Oncol 13 (2023):1132424.PMID:37251940
- J Enzym Inhib Med Ch 39.1 (2024):2288810.PMID:38059334
- Int J Mol Sci 23.22 (2022):14306.PMID:36430782
- Acs Biomater Sci Eng (2024).PMID:38445959
- Int Immunopharmacol 121 (2023):110413.PMID:37301119
- Am J Cancer Res 13.5 (2023):2135.PMID:37293170
- Lab Chip (2024).PMID:38939907
- Front Cell Dev Biol (2023):1161541.PMID:37325570
- Front Pharmacol 13 (2022):1043022.PMID:36588728
- Mar Life Sci Tech 4.3 (2022):373-383.PMID:37073164
- Front Pharmacol 13 (2022):927488.PMID:35935870
- J Agr Food Chem 71.1 (2022):546-556.PMID:36538589
- Front Pharmacol 13 (2022):946193.PMID:36091823
- Front Immunol 15 (2024):1455996.PMID:39376562
- Biochem Pharmacol (2023):115632.PMID:37263300
- Apoptosis (2024):1-19.PMID:39097858
- Front Cell Dev Biol 9 (2022):793793.PMID:35155447
- Int J Mol Med 54.6 (2024):1-17.PMID:39364745
- Ecotox Environ Safe 233 (2022):113315.PMID:35189521
- Exp Neurol 359 (2023):114266.PMID:36336032
- Int Immunopharmacol 131 (2024):111922.PMID:38522137
- Front Oncol 12 (2022):858598.PMID:35321435
- Cancer Cell Int 21 (2021):1-12.PMID:34281530
- Int Immunopharmacol 113 (2022):109342.PMID:36327871
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Front Immunol 15 (2024):1375781.PMID:39391314
- Bba-Mol Basis Dis (2024):167210.PMID:38704001
- Aging (Albany NY) 16.11 (2024):9625.PMID:38829771
- Cns Neurosci Ther (2023).PMID:37452510
- Ecotox Environ Safe 289 (2025):117511.PMID:39662457
- J Nutr Biochem (2024):109678.PMID:38844080
- Jci insight 9.15 (2024):PMID:38935435
- J Transl Med 22.1 (2024):1-15.PMID:39256832
- Biomolecules 12.9 (2022):1283.PMID:36139122
- Resp Res 24.1 (2023):216.PMID:37674165
- Stem Cell Transl Med (2024):szae020.PMID:38530131
- Mol Neurobiol 59.12 (2022):7075-7094.PMID:36083519
- Front Pharmacol 12 (2021):673263.PMID:34108880
- Cancer Cell Int 24.1 (2024):123.PMID:38566075
- Mol Med 30.1 (2024):1-18.PMID:39266965
- J Transl Med 22.1 (2024):1-17.PMID:39267037
- Front Bioeng Biotech 12 (2024):1361682.PMID:38562665
- Front Pharmacol 12 (2021):649398.PMID:34335241
- Am J Physiol-Cell Ph (2024).PMID:38525543
- Int-Immunopharmacol 124 (2023):110809.PMID:37690240
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Cancer Gene Ther (2021)1-12.PMID:33888871
- J Mater Chem B (2024).PMID:39119756
- Apoptosis 28.3-4 (2023):414-431.PMID:36482019
- Front Oncol 12 (2022):770628.PMID:35372056
- Acs Biomater Sci Eng (2024).PMID:38446137
- Front Immunol 15 (2024):1455996.PMID:39376562
- J Agr Food Chem 70.50 (2022):15763-15775.PMID:36472370
- Am J Chinese Med (2024):1-23.PMID:38490807
- Int Immunopharmacol 132 (2024):111870.PMID:38547771
- Cancer Cell Int 23.1 (2023):142.PMID:37468908
- J Ethnopharmacol 310 (2023):116375.PMID:36934787
- Molecules 27.23 (2022):8568.PMID:36500666
- Macromol Biosci (2024):2400003.PMID:38597147
- Bioorg Chem 136 (2023):106556.PMID:37105002
- Front Endocrinol 13 (2022):998971.PMID:36147560
- Molecules 27.17 (2022):5698.PMID:36080465
- Sci Rep-Uk 13.1 (2023):14339.PMID:37658227
- J Dent (2024):105436.PMID:39488296
- Mol Carcinogen (2023).PMID:37750597
- Aging (Albany NY) 15.23 (2023):14292.PMID:38059876
- Faseb J 38.7 (2024):e23591.PMID:38572579
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Environ Toxicol (2023).PMID:38069587
- Cell Signal (2023):110987.PMID:38029946
- Arch Toxicol (2024):1-16.PMID:38971901
- J Neurochem 164.5 (2023):643-657.PMID:36527420
- J Virol (2023):e00549-23.PMID:37222617
- Pharmaceuticals 15.10 (2022):1271.PMID:36297383
- J Ethnopharmacol (2024):119272.PMID:39716512
- Life Sci 254 (2020):117793.PMID:32416164
- Pharmaceuticals 15.11 (2022):1435.PMID:36422564
- Aging 16.8 (2024):6773-6795.PMID:38643468
- Microorganisms 11.5 (2023):1268.PMID:37317242
- Front Endocrinol 13 (2022):657802.PMID:36263320
- Cell Cycle 21.3 (2022):228-246.PMID:34965191
- J Cell Mol Med 26.13 (2022):3783-3796.PMID:35656815
- Invest Ophth Vis Sci 63.6 (2022):13-13.PMID:35695808
- Toxicology (2024):154018.PMID:39608440
- Front Oncol 12 (2022):961653.PMID:36457504
- Molecules 27.14 (2022):4603.PMID:35889477
- Front Oncol 12 (2022):1043161.PMID:36439418
- Acs Appl Bio Mater (2024).PMID:38700956
- Environ Toxico (2024).PMID:38700384
- Int Immunopharmacol 141 (2024):112955.PMID:39163685
- J Oncol 2022 (2022).PMID:36281290
- J Cell Mol Med 24.7 (2020):4136-4149.PMID:32100443
- Int Immunopharmacol 138 (2024):112625.PMID:38996666
- Am J Physiol-Cell Ph (2024).PMID:39069827
- Bone Joint Res 13.12 (2024):763-777.PMID:39662502
- Biochem Pharmacol (2024):116438.PMID:39025409
- J Ethnopharmacol (2024):119073.PMID:39522846
- Mol Neurobiol (2024):1-18.PMID:38995443
- Drug Deliv Transl Re (2023):1-13.PMID:37130996
- J Virol 97.11 (2023):e00719-23.PMID:37929962
- Am J Physiol-Gastr L (2024).PMID:38742280
- Transl Oncol 52 (2025):102256.PMID:39733744
- J Dent (2024):105436.PMID:39488296
- Front Cell Dev Biol 12 (2024):1391873.PMID:39170916
- Bone Joint Res 13.12 (2024):763.PMID:39662502
- Molecules 28.6 (2023):2426.PMID:36985397
- Biotechnol J 19.1 (2024):2300453.PMID:37899497
- Mol Carcinogen 62.2 (2023):160-173.PMID:36222184
- Acs Biomater Sci Eng (2024).PMID:39164198
- Diabetol Metab Syndr 16.1 (2024):1-14.PMID:38317244
- Aging (Albany NY) 16.8 (2024):6773.PMID:38643468
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Clin Immunol (2024):110308.PMID:39002794
- J Ethnopharmacol (2024):117865.PMID:38369066
- Front Oncol 12 (2022):996080.PMID:36483054
- J oncol 2022 (2022).PMID:36385962
- Cell Death Discov 8.1 (2022):85.PMID:35220396
- Chem-Biol Interact 382 (2023):110638.PMID:37473910
- J Ethnopharmacol 307 (2023):116193.PMID:36746295
- Acs Infect Dis 8.9 (2022):1851-1868.PMID:35948057
- Int J Mol Med 52.5 (2023):1-14.PMID:37800609
- Mol Nutr Food Res (2024):2300912.PMID:38847553
- Biochem Pharmacol (2024):116688.PMID:39617210
- J Ethnopharmacol (2024):118685.PMID:39127116
- J Ethnopharmacol (2024):117958.PMID:38395179
- J Ethnopharmacol (2024):117985.PMID:38417600
- J Nutr Biochem (2024):109780.PMID:39395694
- Burns Trauma 12 (2024):tkae001.PMID:38434722
- Sci Rep-Uk 13.1 (2023):361.PMID:36611103
- J Ethnopharmacol (2023):116731.PMID:37277084
- Glia (2024).PMID:39610064
- J Cell Mol Med 28.6 (2024):e18223.PMID:38451046
- J Oncol 2022 (2022).PMID:36213831
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Eur-J Pharmacol 958 (2023):176033.PMID:37673365
- J Oncol 2022 (2022):6459029PMID:36199788
- J Ethnopharmacol 319 (2024):117091.PMID:37634753
- Transl Oncol 47 (2024):102042.PMID:38924847
- J Ethnopharmacol 319 (2024):117205.PMID:37741473
- J Hepatocell Carcino (2023):863-881.PMID:37313303
- Int Immunopharmacol 107 (2022):108695.PMID:35305385
- J-Ethnopharmacol (2023):116729.PMID:37277081
- Redox Rep 29.1 (2024):2398380.PMID:39284588
- Radiother Oncol (2024):110686.PMID:39709027
- Int Immunopharmacol 108 (2022):108742.PMID:35378447
- Int Immunopharmacol 138 (2024):112559.PMID:38955028
- Cell Signal 113 (2024):110962.PMID:37931691
- J Oncol 2022 (2022).PMID:36213838
- Int Immunopharmacol 138 (2024):112539.PMID:38936054
- Life Sci (2024):123148.PMID:39447733
- Bioengineering 9.9 (2022):433.PMID:36134979
- Cell Cycle 21.8 (2022):835-850.PMID:35100080
- Mol Neurobiol 59.8 (2022):4776-4790.PMID:35622272
- Molecules 27.21 (2022):7183.PMID:36364008
- Cell Cycle 19.17 (2020):2139-2147.PMID:32779548
- Macromol Biosci (2024):2400003.PMID:38597147
- Am J Cancer Res 14.1 (2024):324.PMID:38323285
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- J Ethnopharmacol (2024):118080.PMID:38521426
- J Dermatol Sci 109.2 (2023):52-60.PMID:36858850
- J Inflamm Res (2024):10533-10546.PMID:39659750
- Brain Res Bull (2024):111165.PMID:39667505
- Rsc Adv 13.33 (2023):23010-23020.PMID:37529353
- Biomed Mater 18.6 (2023):065026.PMID:37852221
- Langmuir 39.39 (2023):14162-14172.PMID:37722015
- Front Pharmacol 15 (2024):1453938.PMID:39654626
- Eur J Pharm Biopharm (2024):114417.PMID:39013493
- Front Oncol 14 (2024):1471109.PMID:39582546
- Mol Cell Biochem (2024):1-15.PMID:39179754
- Gene (2024):148399.PMID:38518902
- Sci Rep-Uk 14.1 (2024):21680.PMID:39289451
- Bmc Complement Med 24.1 (2024):1-16.PMID:38580999
- Acta Derm-Venereol 104 (2024).PMID:38590175
- Bmc Cancer 24.1 (2024):465.PMID:38622522
- Eur J Pharmacol (2024):176995.PMID:39277096
- Rsc Adv 14.18 (2024):12864-12872.PMID:38650686
- Toxicol Sci (2024):kfae054.PMID:38636494
- Front Pharmacol 15 (2024):1424624.PMID:25956975
- Heliyon (2024).PMID:38707472
- Pediatr Res (2024):1-10.PMID:38658662
- Cancer Biol Ther 25.1 (2024):2325126.PMID:38445610
- Sci Rep-Uk 14.1 (2024):19292.PMID:39164313
- Sci Rep-Uk 14.1 (2024):18929.PMID:39147857
- Bmc Complement Med 24 (2024).PMID:38783288
- Cancer Biol Ther 25.1 (2024):2355705.PMID:38778753
- Bba-Mol Basis Dis (2024):167467.PMID:39159699
- Aging (Albany NY) 16.14 (2024):11339.PMID:39029955
- J Immunother (2024):10-1097.PMID:38847148
- Sci Rep-Uk 14.1 (2024):14438.PMID:38910141
- J Biol Chem (2024):107499.PMID:38944125
- Front Pharmacol 15 (2024):1397761.PMID:39104391
- Bba-Mol Basis Dis (2024):167354.PMID:39004378
- J Biochem Mol Toxic 38.4 (2024):e23675.PMID:38488158
- Bmc Cancer 24.1 (2024):1-16.PMID:38475728
- J Steroid Biochem (2023):106429.PMID:38035949
- Endocrine (2024).PMID:38191984
- Sci Rep-Uk 14.1 (2024):27063.PMID:39511266
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Gene (2023):148050.PMID:38042211
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Toxicol Appl Pharm (2023):116794.PMID:38142782
- Sci Rep-Uk 14.1 (2024):25636.PMID:39465338
- Oral Dis (2024).PMID:38168877
- J Cell Mol Med 28.20 (2024):e70163.PMID:39462268
- Gerontology (2024).PMID:38168028
- J Gen Virol 105.1 (2024):001944.PMID:38180473
- Cytokine 176 (2024):156507.PMID:38244240
- Microbiol Spectr (2024):e04142-23.PMID:38421191
- Zool Res 45.5 (2024):1001.PMID:39147715
- Front Oncol 14 (2024):1440906.PMID:39346724
- Eur J Pharmacol 983 (2024):176995.PMID:39277096
- Endocrine (2024):1-14.PMID:38378893
- J Biochem Mol Toxic 38.1 (2024):e23544.PMID:37815058
- Zool Res 45.5 (2024).PMID:39147715
- Environ Toxicol (2024).PMID:39400944
- Bmc Chem 18.1 (2024):1-11.PMID:39396055
- J Pharmacol Exp Ther 388.3 (2024):827-845.PMID:38262745
- Bmc Genomics 25.1 (2024):1-13.PMID:38395755
- Metabolomics 20.5 (2024):112.PMID:39369160
- J Cancer 15.5 (2024):1397.PMID:38356722
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Epigenetics-Us 18.1 (2023):2254976.PMID:37691391
- Front Genet 13 (2022):959109.PMID:36147489
- Int J Mol Med 49.3 (2022):1-11.PMID:35014672
- Thorac Cancer 13.5 (2022):761-770.PMID:35098684
- Bioorgan Med Chem 72 (2022):116994.PMID:36087428
- Hypertens Res 45.4 (2022):650-664.PMID:35082376
- Bioorgan Med Chem 82 (2023):117234.PMID:36906964
- Front Genet 13 (2022):932973.PMID:36118847
- Inflammation 45.1 (2022):372-386.PMID:34792688
- J Oncol 2022 (2022).PMID:35518787
- Biotechnol Genet Eng (2023):1-17.PMID:36946780
- J Neuro Oncol (2023):1-16.PMID:37351767
- Am J Transl Res 13.10 (2021):11255.PMID:34786056
- Toxicol Lett 379 (2023):20-34.PMID:36905973
- Bmc Cancer 21.1 (2021):1181.PMID:34740322
- Oncol Rep 46.6 (2021):1-12.PMID:34643248
- Bmc Cancer 22.1 (2022):1-14.PMID:35387643
- Ann Transl Med 10.24 (2022).PMID:36660714
- Bmc Cancer 21.1 (2021):1-15.PMID:34130645
- Metab Brain Dis 38.1 (2023):255-267.PMID:36445630
- Biotechnol Genet Eng (2023):1-15PMID:37018431
- Environ Toxicol (2023).PMID:37052456
- Bioscience Rep 43.5 (2023):BSR20230028.PMID:37083601
- Bmc Med Genomics 15.1 (2022):1-19.PMID:36503492
- Mol Immunol 153 (2023):126-134.PMID:36495817
- Neurochem Res (2023):PMID:37127800
- Neurotox Res 40.6 (2022):1895-1901.PMID:36223054
- Hum Cell 35.4 (2022):1140-1158.PMID:35581525
- Mol Immunol 152 (2022):27-34.PMID:36244215
- J Biochem Mol Toxice 36.11 (2022):e23200.PMID:35997646
- Pharm Biol 60.1 (2022):1436-1448.PMID:35938494
- Metab Brain Dis 37.7 (2022):2349-2362.PMID:35779150
- Brain Res Bull 187 (2022):1-10.PMID:35738501
- Neuroscience (2023).PMID:37286157
- Transl Oncol 14.12 (2021):101219.PMID:34555726
- Heliyon 8.11 (2022).PMID:36353164
- J Ethnopharmacol 278 (2021):114275.PMID:34087404
- Acta Diabetol 58.9 (2021):1251-1267.PMID:33907874
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- J Cancer 11.5 (2020):1162.PMID:31956362
- Rsc Adv 13.32 (2023):22367-22374.PMID:37497090
- Oncotargets Ther (2020):2511-2522.PMID:32280236
- Spectrochim Acta A 237 (2020):118387.PMID:32416513
- J Ethnopharmacol 259 (2020):112956.PMID:32442587
- Oncotargets Ther (2020):11301-11313.PMID:33177838
- Sci Rep-Uk 10.1 (2020):20623.PMID:33244088
- Toxicol Appl Pharm 410 (2021):115361.PMID:33285147
- Mol Cell Biochem (2023):1-11.PMID:36939994
- Toxicol Appl Pharm 422 (2021):115559.PMID:33961903
- Mol Cells 46.4 (2023):231-244.PMID:36625319
- Oncol Rep 46.1 (2021):1-12.PMID:34080652
- Chem Biol Drug Des 104.1 (2024):e14580.PMID:39031936
- Bmc Oral Health 24 (2024):1421.PMID:39574093
- Mol Biotechnol 64.12 (2022):1367-1375.PMID:35639278
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Future Microbiol 0 (2024).PMID:38629914
- Bba-Gen Subjects (2024):130628.PMID:38642815
- Dis Markers 2022 (2022).PMID:35845132
- Bioengineered 12.1 (2021):5985-5995.PMID:34477479
- Cell Mol Biol Lett 24.1 (2019):1-14.PMID:31889958
- Biomarkers (2024):1-12.PMID:38568742
- Dis Markers 2022 (2022).PMID:35845132
- N-S Arch Pharmacol (2024):1-21.PMID:39549064
- Curr Stem Cell Res T 19.7 (2024):1021-1028.PMID:37861049
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Bioengineered 12.1 (2021):6687-6702.PMID:34516362
- J Pharm Pharmacol 71.9 (2019):1412-1420.PMID:31282010
- Dis Markers 2022 (2022).PMID:35968506
- Eur Rev Med Pharmaco 23.5 (2019).PMID:30915737
- Plos One 19.12 (2024):e0316362.PMID:39724098
- Heliyon (2024):.PMID:37461802
- J Mol Neurosci 74.1 (2024):30.PMID:38478195
- Tissue Cell 80 (2023):102001.PMID:36565506
- Thorac Cancer 14.9 (2023):815-826.PMID:36737402
- S Afr J Bot 177 (2025):445-456.
- Pharmacology 108.2 (2023):166-175.PMID:36724745
- Gene 932 (2025):148898.PMID:39209182
- Bioengineered 13.5 (2022):11987-12002.PMID:35603556
- Bosn J Basic Med Sci 20.3 (2020):357.PMID:31733641
- Tissue Cell (2024):102477.PMID:39018712
- Mol Biol Rep 51.1 (2024):1-13.PMID:39422836
- Mol Cell Biochem 476 (2021):1387-1400.PMID:33389498
- Bmc Cancer 24.1 (2024):1-21.PMID:39085784
- Bioengineered 12.2 (2021):11936-11946.PMID:34784841
- J Appl Toxicol 42.5 (2022):830-840.PMID:34708435
- Bioengineered 12.1 (2021):8698-8708.PMID:34697986
- Discov Oncol 15.1 (2024):280.PMID:39004679
- Technol Cancer Res T 19 (2020).PMID:33111613
- Bioengineered 12.2 (2021):11451-11460.PMID:34895055
- Bioengineered 13.1 (2022):1518-1529.PMID:34986734
- Bioengineered 13.1 (2022):455-468.PMID:34967265
- J Mol Neurosci 72.2 (2022):433-440.PMID:35023001
- Microb Pathogenesis (2024):107055.PMID:39442820
- Mol Cell Biochem 473 (2020):179-192.PMID:32627113
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Cell Stress Chaperon 25 (2020):955-968.PMID:32572784
- Acta Bioch Bioph Sin 56.5 (2024):776.PMID:38495003
- Chem Biol Drug Des 99.6 (2022):828-838.PMID:35184389
- Bioengineered 13.3 (2022):6650-6664.PMID:35230214
- Bioengineered 13.3 (2022):6807-6818.PMID:35246020
- Hum Mol Genet (2024):ddae122.PMID:39216871
- Oncol Res 32.6 (2024):1129.PMID:38827325
- Curr Pharm Biotechno 23.8 (2022):1101-1108.PMID:34463226
- Mol Biotechnol (2024):1-15.PMID:38771419
- J Mol Histol (2024):1-8.PMID:38758519
- J Sci Food Agr (2024).PMID:39394871
- Discov Oncol 15.1 (2024):309.PMID:39060620
- Virus Res 313 (2022):198748.PMID:35304133
- Bioengineered 13.4 (2022):10335-10349.PMID:35435110
- Shock 59.3 (2023):426-433.PMID:36609531
- J Orthop Surg Res 18.1 (2023):910.PMID:38031136
- Shock (2023):10-1097.PMID:37179246
- Luminescence 39.1 (2024):e4671.PMID:38286599
- Planta Med 89.05 (2023):493-507.PMID:35716667
- Clin Exp Pharmacol P 50.11 (2023):903-913.PMID:37635387
- Clinics 77 (2022).PMID:35662010
- Int J Chronic Obstr (2023):919-932.PMID:37229441
- J Tradit Chin Med 43.4 (2023):744.PMID:37454259
- Mol Med Rep 28.5 (2023):1-12.PMID:37732544
- N S Arch Pharmacol (2023):1-13.PMID:37160483
- FEBS Open Bio 12.1 (2022):146-153.PMID:34644456
- Shock (2023):10-1097.PMID:37988072
- Cell Transplant 33 (2024).PMID:38334047
- Fitoterapia (2024):106245.PMID:39393711
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Endocr Metab Immune 24.1 (2024):153-162.PMID:37150983
- Cell J 24.1 (2022):15.PMID:35182060
- Acta Histochem 125.8 (2023):152097.PMID:37813066
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Hematology 28.1 (2023):2220522.PMID:37272581
- Neuroreport 33.10 (2022):413.PMID:35623086
- Anticancer Res 43.8 (2023):3411-3418.PMID:37500147
- J Int Med Res 48.4 (2020).PMID:31891283
- Pathol Res Pract 217 (2021):153284.PMID:33249400
- Genes Genom (2023):1-15.PMID:37318704
- Adv Clin Exp Med 30.10 (2021):1031-1041.PMID:34329545
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Vet Parasitol 331 (2024):110284.PMID:39126893
- Discov Oncol 14.1 (2023):1-10.PMID:37907650
- Bmc Nephrol 24.1 (2023):314.PMID:37884904
- Vet Parasitol (2024):110284.PMID:39126893
- J Asian Nat Prod Res 24.11 (2022):1078-1085.PMID:34935551
- J Obstet Gynaecol Re PMID:39169658
- Pediatr Surg Int 39.1 (2022):54.PMID:36534156
- Immunobiology (2024):152832.PMID:38943814
- Cell Mol Biol 69.12 (2023):223-231.PMID:38063090
- Ann Hepatol 27.4 (2022):100700.PMID:35338010
- Chin J Integr Med (2024):1-11.PMID:38941045
- Cell J 24.1 (2022):15.PMID:35182060
- Curr Cancer Drug Tar 24.9 (2024):975-986.PMID:38204265
- Aesthet Plast Surg (2023):1-11.PMID:38148357
- Int J Gen Med (2022):3199-3213.PMID:35342302
- J Obstet Gynaecol Re PMID:39169658
- Clin Hemorheol Micro (2023):1-15.PMID:37212088
- Exp Ther Med 20.4 (2020):3290-3300.PMID:32855700
- Int J Gen Med (2022):3199-3213.PMID:35342302
- J Int Med Res 49.3 (2021).PMID:33730930
- J Cardiothorac Surg 18.1 (2023):222.PMID:37420297
- Balk Med J 41.6 (2024).PMID:39319820
- Cell J 25.8 (2023):554.PMID:37641417
- Oncol Res 33.1 (2024):103.PMID:39735676
- Am J Transl Res 15.7 (2023):4873.PMID:37560235
- N S Arch Pharmacol (2023):1-13.PMID:37052642
- Comb Chem High T Scr (2024).PMID:35894460
- World J Oncol (2024):.
- J Toxicol Sci 48.8 (2023):469-479.PMID:37532580
- Anim Biotechnol (2023):1-12.PMID:36756956
- J Membrane Biol 253 (2020):43-55.PMID:31820013
- Cell Mol Biol 70.2 (2024):161-168.PMID:38430026
- Am J Transl Res 14.10 (2022):6964.PMID:36398260
- Pediatr Surg Int 40.1 (2024):63.PMID:38431920
- J Int Med Res 48.4 (2020).PMID:31891283
- Curr Mol Pharmacol 17.1 (2024).PMID:36946474
- Balk Med J 41.6 (2024):491.PMID:39319820
- Biochem Genet (2023):1-18.PMID:37148331
- Iran J Immunol (2023).PMID:37865874
- J Craniofac Surg 33.4 (2022):1250-1254.PMID:36041089
- Transpl P 52.1 (2020):398-405.PMID:31928781
- Transl Cancer Res 13.4 (2024).PMID:38737693
- J Nutr Biochem (2024):109769.PMID:9276944
- Int J Mol Sci 24.19 (2023):15003.PMID:37834451
- Front Bioeng Biotech 12 (2024):1460870.
- Gene (2024) 149056.
- Plos Pathog 19.4 (2023):e1011305.PMID:37053288
- J Hazard Mater (2024) 135735.
- Fiber Polym (2022):1-9.
- Int J Nanomed (2023):5423-5440.PMID:37767196
- J Inflamm Res 14 (2021):3523.PMID:34335041
- J Inflamm Res 14 (2021):2445.
- HemaSphere 5.7 (2021).PMID:34136753
- Front Pharmacol 15 (2024):1384141@0.jpg
- J Integr Med-Jim (2024).
- Int J Biol Sci 20.12 (2024):4713-4730.
- Appl Entomol Zool (2022):1-14.
- Acs Appl Nano Mater (2024).
- Front Pharmacol 15:1453938.
- Oxid Med Cell Longev 2021 (2021):1-30.PMID:34257808
- Faseb J 38.15 (2024):e23876.
- Bioact Mater 43 (2025):32-47.
- Cancer Manag Res (2021):4709-4723.PMID:34163246
- bioRxiv (2024) 2024-10.
- J Clean Prod 315 (2021):128201.
- Food Hydrocolloid 120 (2021):106980.
- Ecotox Environ Safe 286 (2024):117233.
- Dis Markers 2021 (2021):1-12.PMID:34413913
- Biomed Res Int 2021 (2021).PMID:34373837
- Bioorg Chem (2024):107731.
- Crit Rev Eukar Gene 34 (2024).
- Exp Ther Med 26.5 (2023):1-15.PMID:37869642
- Viruses 16.8 (2024):1239.
- J Environ Pathol Tox 42 (2023).PMID:36749091
- Small (2024):2402308.PMID:3911
- Acs Appl Mater Inter (2024).PMID:39167710
- Iscience 26.9 (2023).PMID:37670789
- Vaccines-Basel 11.11 (2023):1678.PMID:38006011
- Phytochem Lett 46 (2021):79-89.
- Front Immunol 14 (2023).PMID:37901236
- Nano Res (2022):1-8.
- Cells 10.9 (2021):2399.PMID:34572049
- Adv Funct Mater 29.50 (2019):1906690.
- Cell Mol Biol 69.5 (2023):44-50.PMID:37571902
- J Funct Foods 123 (2024):106621.
- J King Saud Univ Sci 32.7 (2020):2912-2919.
- Int J Mol Sci 22.16 (2021):8898.PMID:34445601
- Nanomaterials 11.8 (2021):2008.PMID:34443839
- Int J Mol Sci 24.21 (2023):15545.PMID:37958531
- Acta Pharmacol Sin 44.1 (2023):255-257.PMID:35773339
- Int Immunopharmacol 123 (2023):110709.PMID:37515849
- Biomed Pharmacother 179 (2024):117370.
- Drug Des Dev Ther (2024):5841-5851.
- Sensor Actuat B Chem 394 (2023):134396.
- J Transl Med 22.1 (2024) 1-16.
- ACS omega 8.30 (2023):27146-27155.PMID:37546678
- Exp Eye Res 209 (2021):108642.PMID:34058232
- Phytother Res 34.4 (2020):836-845.
- Mol Ther Nucl Acids (2020).
- Front Cell Neurosci 15 (2021):569424.PMID:33815059
- Biomaterials 272 (2021):120757.PMID:33798960
- Carbohyd Polym 277 (2022):118869.PMID:34893274
- Front Cell Dev Biol 8 (2021):568304.PMID:33763412
- J Biol Chem 297.2 (2021).PMID:33722608
- Drug Dev Res 81.4 (2020):437-443.PMID:31904108
- Microorganisms 11.9 (2023):2258.PMID:37764102
- Front Pharmacol 11 (2021):618262.PMID:33551818
- Mater Res Express 7.2 (2020):025401.
- Mol Cell Toxicol (2023):1-10.
- scienceasia (2024).
- Heliyon (2024).
- Open Med-Warsaw 16.1 (2021):558-569.PMID:33869778
- Biomedicines 12.11 (2024):2543.
- Anal Cell Pathol 2020 (2020).PMID:33354489
- Bioact Mater 44 (2025):220-235.
- Appl Entomol Zool 58.4 (2023):303-313.
- Biosens Bioelectron (2024):116875.
- Carbohyd Polym (2024):122897.
- Drug Resist Update (2024):101161.
- Crystals 13.7 (2023):1067.
- Poultry Sci 102.10 (2023):102946.PMID:37542939
- Mol Cell Oncol 10.1 (2023):2238873.PMID:37649964
- New J Chem 48.11 (2024):5068-5073.
- Int J Mol Sci 21.21 (2020):8095.PMID:33142980
- J Hazard Mater (2024):136113.
- Phytomedicine 86 (2021):153565.PMID:33945919
- Biochip J (2023):1-10.
- Compos Part B-Eng 220 (2021):108984.PMID:35988999
- Int J Mol Sci 25.20 (2024):11184.
- Antioxidants-Basel 13.11 (2024):1289.
- Acs Appl Bio Mater 4.6 (2021):5026-5032.
- Diabet Metab Synd Ob (2021):2255-2268.PMID:34045875
- Antioxidants 13.11 (2024) 1320.
- J-Ethnopharmacol 318 (2024):116961.PMID:37541404
- J Transl Med 22.1 (2024):1-16.
- Biocell 47.8 (2023).
- Front Oncol 10 (2020):387.
- J-Ethnopharmacol 318 (2024):116969.PMID:37516391
- Phytomedicine (2024):156091.
- Aging (Albany NY) 15.12 (2023):5713PMID:37390121
- Trop J Pharm Res 22.9 (2023):1857-1862.
- Mol Ther-Nucl Acids (2020).
- Int J Mol Sci 25.19 (2024):10339.
- Vaccines Basel 11.7 (2023):1190.PMID:37515006
- Heliyon (2024).
- Int J Mol Sci 25.19 (2024):10496.
- J Pharm Sci 75.10 (2020):505-509.PMID:33305726
- Pharmaceuticals-Base 17.10 (2024):1295.
- Mol Biotechnol 63.8 (2021):686-693.PMID:33977498
- Chem Eng J (2024):156542.
- Pharmaceuticals-Base 16.10 (2023):1482.PMID:37895953
- Trop J Pharm Res 22.9 (2023):1779-1784.
- Mater Express 10.1 (2020):102-111.
- Front Immunol 15 (2024):1347683.PMID:38343537
- Food Sci Nutr (2023).
- Int J Mol Sci 25.15 (2024):8340.
- Viruses 14.8 (2022):1783.PMID:36016405
- Redox Biol (2024):103143.
- Dis Markers 2022 (2022).
- Nanoscale (2024).
- J Agr Food Chem (2024).
- Discov Oncol 13.1 (2022):71.PMID:35941331
- Int J Mol Sci 23.16 (2022):9014.PMID:36012290
- Ceram Int 49.15 (2023):25953-25963.
- Colloid Surface B 228 (2023):113364.PMID:37290201
- J Oncol 2022 (2022).PMID:36059813
- Int J Mol Sci 25.2 (2024):919.
- J Thorac Dis 15.4 (2023):2198.PMID:37197522
- New J Chem 48.11 (2024):5068-5073.PMID:PMID
- Molecules 27.16 (2022):5337.PMID:36014573
- Cancers 14.19 (2022):4645.PMID:36230568
- Acs Appl Opt Mater (2024).
- Oxid Med Cell Longev 2022 (2022).PMID:35936222
- Exp Ther Med 27.5 (2024):1-16.
- Transl Cancer Res 11.6 (2022):1781.PMID:35836521
- Adv Funct Mater (2023):2214998.
- Mater Today Adv 15 (2022):100271.
- Pharmaceuticals-Base 17.4 (2024):515.
- Oncol Lett 26.1 (2023):1-17.
- Cells 13.9 (2024):728.
- Phytomedicine (2024):155347.
- Sensors & Diagnostics (2024).
- J Oncol 2022 (2022).PMID:35909906
- Carbohyd Polym 295 (2022):119878.PMID:35989018
- Applied Sciences 14.8 (2024):3186.
- Adv Funct Mater (2024):2402663.
- Phytomedicine 105 (2022):154330.PMID:35905566
- Acs Pharmacol Transl (2024).
- Heliyon (2024).
- Phytother Res 37.2 (2023):477-489.PMID:36199227
- Pharmaceutics 14.10 (2022):2157.PMID:36297592
- Foods 11.11 (2022):1575.PMID:35681325
- Antioxidants Basel 13.3 (2024):264.
- J Funct Foods 114 (2024):106076.
- bioRxiv (2023):2023-05.PMID:37292976
- Front Immunol 15 (2024):1326137.
- Poultry Sci 102.4 (2023):102511.PMID:36805396
- Mol Med 29.1 (2023):6.PMID:36647009
- Oxid Med Cell Longev 2023 (2023).PMID:36778205
- New J Chem (2024).
- Drug Develop Res 84.2 (2023):312-325.PMID:36658741
- Kaohsiung J Med Sci (2024).PMID:38340032
- Int J Pept Res Ther 29.2 (2023):19.
- J Ethnopharmacol (2024):117867.PMID: 38342155
- Int J Mol Sci 24.7 (2023):6279.PMID:37047251
- J Inflamm Res (2023):1045-1057.PMID:36936349
- J Biomed Nanotechnol 20.1 (2024):133-142.
- Sensor Actuat B-Chem 381 (2023):133437.
- Aquaculture 564 (2023):739060.
- Biomaterials Advances 142 (2022):213165.PMID:36341744
- Cell Death Dis 15.1 (2024):97.PMID:38286802
- Cancers 14.21 (2022):5218.PMID:36358640
- J Agr Food Chem 70.44 (2022):14220-14234.PMID:36300841
- Cells 11.22 (2022):3580.PMID:36429010
- Fitoterapia (2024):105884.
- Eur J Med Chem (2024):116323.PMID:(2024) 116323.
- Curr Issues Mol Biol 45.5 (2023):4017-4034.PMID:37232725
- Mol Cell Toxicol (2022):1-11.
- Mater Design (2024):112812.
- Histol Histopathol 35.9 (2020):919-927.PMID:32282924
- Mater Today Bio (2024):100958.
- bioRxiv (2024):2024-02.
- Acs Appl Bio Mater 6.1 (2023):74-82.PMID:36603189
- Mater Today Chem 27 (2023):101331.
- Int J Mol Sci 24.2 (2023):1243.PMID:36674761
- Exp Ther Med 25.2 (2023):1-10.PMID:PMID_36684652
- Oxid Med Cell Longev 2022 (2022).PMID:35770048
- Adv Funct Mater (2024):2305827.
- Front Microbiol 14 (2023).PMID:37645224
- Pharmaceutics (2023) 15(12):2713.
- Exp Ther Med 23.2 (2022):1-9.PMID:35069839
- bioRxiv (2022):2022-04.
- Int J Bioprinting (2024).
- Bio-Des Manuf 5.2 (2022):358-370.
- Green Process Synth 13.1 (2024):20240050.
- Bioact Mater 36 (2024):524-540.
- Am J Cancer Res (2024):2852-2867.
- Nano Today 41 (2021):101326.
- Int J Biol Sci 20.2 (2024):433-445.PMID:37379961
- Phytochem Lett 47 (2022):174-179.
- Netw Model Anal Hlth 13.1 (2024):1-15.
- Int J Gen Med (2023):5817-5839.PMID:38106976
- Transl Cancer Res 11.1 (2022):206.PMID:35261897
- Tissue Cell 76 (2022).PMID:35182988
- Exp Ther Med 23.2 (2022):1-9.PMID:35069838
- Front Mar Sci 9 (2022):861117.
- Biomed Pharmacother 170 (2024):116042.PMID:38118351
- Acs Omega (2024).
- J Tradit Compl Med (2024).
- Indian J Pharm Sci 86.3 (2024).
- Heliyon (2024).
- Ann Hematol (2023):1-12.
- PeerJ 9 (2021):e11482.PMID:34820154
- Nanophotonics 11.22 (2022):5089-5100.
- Nutrients 16.14 (2024):2346.
- hLife (2024).
- Nutrients 16.14 (2024):2314.
- J Pharm Anal (2024):101053.
- Biocell 47.8 (2023).
- Toxins 16.7 (2024):319.
- Rev Bras Farmacogn (2024):1-7.
- View-China 4.2 (2023):20220052.
- Tissue Cell 74 (2022):101680.PMID:34808429
- Pharmacol Res 177 (2022):106112.PMID:35122955
- Nano Today 43 (2022):101416.
- Phytomedicine 103 (2022):154199.PMID:35679793
- Cancer Res Commun 2.6 (2022):471-482.PMID:36338546
- Front Pharmacol 15 (2024):1389976.
- Available at SSRN 4830418.
- Acs Appl Polym Mater 4.10 (2022):7014-7024.
- Front Pharmacol 13 (2022):899775.PMID:35571096
- Phytomedicine (2024):155744.
- Front Cell Infect Mi 12 (2022):423.PMID:35573770
- bioRxiv (2024):2024-05.
- Theranostics 14.7 (2024):2687.
- Clin Transl Disc 2.2 (2022):e49.
- Acta Trop 232 (2022):106519.PMID:35584779
- Adv Funct Mater (2024):2400489
- Transl Cancer Res 13.4 (2024).
- Phytomedicine (2024):155656.
- Cytotechnology 74.3 (2022):421-432.PMID:35733701
- Int J Mol Sci 23.8 (2022):4128.PMID:35456945
- Chem Eng J 474 (2023):145358.
- Oncol Rep 51.2 (2024):1-13.PMID:38131250
- J Cancer 15.13 (2024):4244-4258.
- Bba-Mol Cell Biol L 1867.6 (2022):159137.PMID:35247568
- Chin Herb Med (2024).
- Acs Omega (2024).
- Talanta (2024):126381.
- Adv Funct Mater (2023):2309690.
- Mol Cell Biochem (2024) 1-13.
- Nat Commun 15.1 (2024):4969.PMID:38862489
- Molecular Therapy Oncology (2024).
- Front Oncol 12 (2022):851300.PMID:35392243
- Heliyon (2024).
- Oncol Lett 23.5 (2022):1-8.PMID:35350588
- J Cancer 13.6 (2022):1808.PMID:35399733
- Pharmaceutics 16.6 (2024):744.
- Bioengineered 13.4 (2022):9145-9155.PMID:35363601
- Phytomedicine (2024):155767.
- Int J Mol Sci 25.24 (2024):13439.
Cell Counting Kit-8 (CCK-8) allows convenient assays using WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(
Cell Counting Kit-8 allows sensitive colorimetric assays for the determination of the number of viable cells in the proliferation and cytotoxicity assays. The detection sensitivity of CCK-8 is superior to that of other tetrazolium salts, including MTT, XTT, and MTS.
Figure 1: Working mechanisms of Cell Counting Kit-8 (CCK-8).
Cell Number Determination
1. Inoculate cell suspension (100 μL/well) in a 96-well plate. Pre-incubate the plate in a humidified incubator (e.g., at 37°C, 5% CO2).
2. Add 10 μL of the CCK8 solution to each well of the plate. Be careful not to introduce bubbles to the wells, since they interfere with the O.D. reading.
3. Incubate the plate for 1 - 4 hours in the incubator.
4. Measure the absorbance at 450 nm using a microplate reader.
Cell Proliferation and Cytotoxicity Assay
1. Seed cells in a 96-well plate at a density of 103-104 cells/well in 100 μL of culture medium to be tested. Culture the cells in a CO2 incubator at 37°C for 24 hours.
2. Add various concentrations of substances to be tested to the plate.
3. Incubate the plate for an appropriate length of time (e.g., 6, 12, 24 or 48 hours) in the incubator.
4. Add 10 μL of CCK8 solution to each well of the plate using a repeating pipettor. Be careful not to introduce bubbles to the wells, since they interfere with the O.D. reading.
5. Incubate the plate for 1 - 4 hours in the incubator.
6. Before reading the plate, it is important to mix gently on an orbital shaker for 1 minute to ensure homogeneous distribution of color.
7. Measure the absorbance at 450 nm using a microplate reader.
Data Analysis
There are several ways to do statistical analysis. You can choose to use O.D. values or cell numbers. We offer one of them.
Cell viability (%) = [(As-Ab) / (Ac-Ab)] × 100
Inhibition rate (%) = [(Ac-As) / (Ac-Ab)] × 100
As = absorbance of the experimental well (absorbance of cells, medium, CCK8 and wells of the test compound).
Ab = blank well absorbance (absorbance of wells containing medium and CCK8).
Ac = control well absorbance (absorbance of wells containing cells, medium and CCK8).
Making a standard curve
1. The cell counting plate counts the number of cells in the cell suspension.
2. Using the medium, the cell suspension is diluted to a concentration gradient, usually requiring 5-7 concentration gradients, several replicate wells per group. Then inoculate the cells. (Note the number of cells per well. If you are diluting the cell suspension in a tube, carefully mix the cells again before adding the wells to the plate. The volume of the cell suspension in each well should be the same.)
3. Incubate until the cells are adherent (usually 2-4 hours), then add 10 μl of CCK8 per 100 μl of medium. Incubation was continued for 1-4 hours, and the absorbance at 450 nm was measured with a microplate reader. Make a standard curve with the number of cells as the X-axis coordinate and the O.D. value as the Y-axis coordinate.
The number of cells of the sample to be tested can be determined based on the curve. A prerequisite for using this standard curve is that the culture conditions are the same.
Precautions
1. Make sure the drug and CCK8 are evenly distributed in the medium.
2. The more cells proliferate, the darker the color; the stronger the cytotoxicity, the lighter the color.
3. For adherent cells, at least 1000 cells per well (100 μl medium). For leukocytes, at least 2500 cells per well (100 μl medium) are required due to their low sensitivity. The recommended 96-well plate has a maximum cell count of 25,000 per well. If the test is performed using a 24-well or 6-well plate, calculate the corresponding number of cells per well and adjust the volume of CCK8 to 10% of the total liquid volume per well.
4. Since the CCK8 assay is based on dehydrogenase activity in living cells, conditions or chemicals that affect dehydrogenase activity may result in a difference between the actual number of viable cells and the number of viable cells measured using CCK8.
5. WST-8 may react with a reducing agent to form WST-8 formazan. If a reducing agent (such as some antioxidants) is used, it will interfere with the test. If more reducing agent is present in the system to be tested, it is necessary to remove it.
6. After 2 hours of incubation, the background O.D. value is typically 0.1-0.2 units.
7. Be careful not to introduce air bubbles into the holes as they will interfere with the O.D. value.
8. If you want to sterilize the CCK8 solution, use a 0.2 μm membrane filter solution.
9. The incubation time will vary depending on the type and amount of cells in the well. Generally, leukocytes are less colored and may require longer incubation times (up to 4 hours) or large numbers of cells (~105 cells/well).
10. If there is high turbidity in the cell suspension, measure and subtract the O.D value of the sample at 600 nm or higher.
11. CCK8 cannot be used for cell staining.
12. The phenol red in the medium does not affect the experimental results. The absorbance of phenol red can be eliminated by subtracting the absorbance of the background in the blank hole during calculation, so it will not affect the detection.
13. The toxicity of CCK8 is very low. After the CCK8 assay is completed, the same cells can be used for other cell proliferation assays, such as crystal violet assay, neutral red assay or DNA fluorescence assay. (Unless the cells are extremely rare, it is not recommended.)
14. This kit can be used in E. coli but not in yeast cells.
15. Before reading the plate, you can mix gently on the shaker.
16. We recommend inoculation of cells in wells near the center of the plate. The medium in the outermost circle of holes is easily evaporated and can be filled with PBS, water or medium.
17. If you don't have a 450 nm filter. You can also use filters with absorbance between 430 and 490 nm, and 450 nm filters for optimum sensitivity.
18. Measure the absorbance at 450 nm. If you need to make a dual wavelength measurement, the absorbance at 650 nm can be determined as the reference wavelength.
19. The presence of metal ions in the drug may affect the sensitivity of CCK8. Lead chloride, iron chloride, and copper sulfate at a final concentration of 1 mM inhibit 5%, 15%, and 90% of the color reaction, reducing sensitivity. If the final concentration is 10 mM, it will be 100% inhibited.
Applications |
1) Cell proliferation determinations-the GlpBio Cell Counting Kit-8 (CCK-8) is water soluble, stable in culture, and non-toxic.
2) Cell viability assays-metabolic activity and dye generation changes in proportion to altered viability. 3) Cytokine assays-measure cytokine-induced proliferation. Cells can be recovered and expanded at the end of the study if desired. 4) Cytotoxicity assays-Cells death from cytotoxic chemicals has no effects on color development, only living cells convert the reagent into a colorimetric indicator. The reagent itself has negligible toxicity, and is generally safe for cells. |
Shipping | Ship with blue ice. |
Storage Conditions | Stored at 4°C protecting from light, and is stable for up to 12 months. Stored at -20°C protecting from light, and is stable for up to 2 years. |
Usage | For research use only! Not for use on humans. |
CCK-8 | MTT | MTS | SRB |
Solubility | Water soluble | Indissolvable | Water soluble | Indissolvable |
Detection Wavelength | 450nm | 490nm | 450nm | 510nm |
Character | Liquid | Solid | Liquid | Liquid |
Usage | No need to prepare | Prepare the solutions | Use it right after it was ready | Prepared beforehand |
Need to redissolve or not | NO | Yes,by DMSO | No | Yes,by Tris-base solution |
Convenience | +++ | ++ | +++ | + |
Detection speed | +++ | + | ++ | + |
Repeatability | +++ | + | ++ | ++ |
Stability | ++ | + | + | +++ |
-
Related Biological Data
Therapeutic targeting of the DDR1–NF-κB–NRF2 axis inhibits PDAC growth and metabolism. a, Parental and E79Q KPC cells plated on wild-type or R/R ECM were incubated in LG medium with or without 7rh, ML120B or ML385. Total viable cells are presented relative to parental cells that were treated with vehicle and plated on wild-type ECM.
Cell viability was determined with a Cell Counting Kit-8 assay (Glpbio).
Nature 610.7931 (2022): 366-372. PMID: 36198801 IF: 69.5026 -
Related Biological Data
LIG1 reversed cell proliferation, apoptosis and DNA damage effects of hsa_circ_0007919 (A-B) CCK-8 analysis of the proliferation of GEM-resistant PDAC cells with or without LIG1 inhibition.
EIPA , IPI549, MBQ-167, MRT68921 or erlotinib, ML385, HCQ or their combinations were added to the wells for 24, 72 or 96 hrs. Next, 10 uL of CCK-8 (GlpBio) was added to each well.
Cancer Cell (2021). PMID: 33740421 IF: 38.5836 -
Related Biological Data
Effect of CrEL on glucose transport.Cell Counting Kit-8 (CCK-8) is a fluorescent glu-cose analog. INK-128 (mTORi) was used as a control for de-creased glucose transport.
Cells after transfection or GEM treatment were collected and counted, then 4 × 103 cells were placed into 96-well plate and cultured in incubator at 37°C. 24, 48, 72 and 96 h after, cells were incubated with 100 μl serum-free medium and 10 μl CCK-8 solution (Glpbio, USA) at 37°C for 2 h and measured at 450 nm wavelength.
Molecular Cancer, 2023, 22(1): 195. PMID: 38044421 IF: 37.2999 -
Related Biological Data
Bifidobacterium cultural supernatant and I3C protected mice against ALF. (G-H) Primary hepatocytes were pre-treated with or without I3C for 1 h followed by PBS or APAP administration for 12 h. The effects of I3C on CCK8 (G) and LDH (H) were detected. n=3-5.
Cell counting kit 8 (CCK8) experiment for in vitro assay were performed using the CCK8 Kit (Glpbio, Cat# GK10001, USA) according to the manufacturer's instructions.
Cell Host & Microbe 32.1 (2024): 48-62. PMID: 38056458 IF: 30.3013 -
Related Biological Data
Fe3O4@IR820@CpG induces immunogenic cell death and promotes DC maturation in vitro. A,B) Viability of MC38 cells after incubation with A) different concentrations of Fe3O4@IR820@CpG without laser irradiation or B) different formulations with 808 nm laser irradiation (1 W cm−2) for 5 min, as detected by CCK-8 kit (n = 4).
Bicinchoninic Acid Assay (BCA) protein assay kit,cell counting kit-8 (CCK-8), and erythrocyte membrane lysates were purchased from GlpBio (Montclair, USA).
Advanced Materials, 2023: 2307193. PMID: 37951210 IF: 29.4006 -
Related Biological Data
H) The viability ofMC38 cells treated with PAD@MS for 48 h in the presence or absence of 10 μM Ferr-1, 20 μM Nec-1, 10 μM z-VAD-FMK, and 1 mM NAC.
Cell viability was detected by cell counting kit-8 (CCK-8) assay (GlpBio, USA) according to the manufacturer’s instruction.
Adv Funct Mater, 2023: 2214998. IF: 19.9246 -
Related Biological Data
After transfection with si-1 and si-2, performed CCK-8 assays were performed to evaluate the cellular growth curves and the results revealed that repressing the expression of PCAT6 remarkably suppressed the cell proliferation of HeLa and SiHa cells.
Each well was added with 10 μl CCK-8 reagent (GLPBIO, Montclair, CA, USA) and the plates were continued to be cultured for 1-2 h. The cell viability was determined by measuring the optical density (OD) absorbance at the wavelength of 450 nm.
Eur Rev Med Pharmacol Sci.2019 Mar;23(5):1947-1956 -
Related Biological Data
Blocking bFGF leads to decrease in cell proliferation and clone formation of cisplatin (DDP) selected A549 cells. Growth curves showed that knocking down bFGF expression resulted in reduction in cell proliferation.
The cells were incubated for 24 h in incubator, and then,10μl CCK-8 (GLPBIO) was added in every well and cultivated at room temperature for 4 h. Absorbance was measured at 450 nm. The experiment repeated three times successive 7 days.
J Pharm Pharmacol.2019 Sep;71(9):1412-1420.
Average Rating: 5
(Based on Reviews and 420 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *